Hemoglobin Optimization to Prevent Transfusion and Adverse Events in Perioperative Patients With Iron Restricted Anemia
Status:
Terminated
Trial end date:
2021-05-31
Target enrollment:
Participant gender:
Summary
The HOPE-Hb trial is a phase II study to determine the feasibility and impact of a
combination treatment (intravenous iron plus erythropoietin) versus intravenous iron
treatment alone on preoperative hemoglobin concentration before hip or knee arthroplasty.
Phase:
Phase 2
Details
Lead Sponsor:
St. Michael's Hospital, Toronto Unity Health Toronto
Treatments:
Epoetin Alfa Ferric Compounds Ferric Oxide, Saccharated Iron